tm logo
REZUROCK
REGISTERED

on 24 May 2023

Last Applicant/ Owned by

KADMON PHARMACEUTICALS LLC

55 Corporate DriveBridgewater NJ 08807

US

Serial Number

2092790 filed on 23rd Jan 2021

Registration Number

TMA1181619 registered on 24th May 2023

Registration expiry Date

23rd Jan 2031

Correspondent Address

SUITE 2308120 ADELAIDE STREET WESTTORONTO

ONTARIO

CA

M5H1T1

REZUROCK

Vienna Information


26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

Trademark usage description

pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories anti-fibrotic properties; pharmaceutical preparations for the prevention Read More

Classification Information


Class [005]
Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories ANTI-Fibrotic properties; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperlipidemia, insulin resistance, metabolic syndrome, the endocrine system, namely growth and thyroid disorders, the musculo-skeletal system and the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders namely dermatitis, skin pigmentation diseases, eczema and psoriasis; pharmaceutical products for the prevention and treatment of respiratory diseases


Classification kind code

11

Mark Details


Serial Number

2092790

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 236
on 21st Jul 2022
Partial Withdrawal - Madrid Protocol
Submitted for opposition 22
on 19th Jul 2022
Search Recorded
Submitted for opposition 20
on 19th Jul 2022
Examiner's First Report
Submitted for opposition 223
on 19th Jul 2022
Total Provisional Refusal
Submitted for opposition 256
on 18th Jan 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 18th Mar 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 17th Mar 2021
Created
Submitted for opposition 31
on 17th Mar 2021
Formalized
Submitted for opposition 228
on 23rd Jan 2021
International Registration
Submitted for opposition 30
on 23rd Jan 2021
Filed